Lemaitre Vascular vs Skinhealth Systems
Skinhealth Systems is the larger business, with $301m of revenue in fiscal 2025 against $250m for Lemaitre Vascular (1.2 times as much). Lemaitre Vascular grew faster (13.5% against -10.0%). Lemaitre Vascular kept more of each dollar of sales as profit: a net margin of 23.1% against -3.2%. Lemaitre Vascular carries less debt relative to equity (42.9% against 596.8%).
| Latest fiscal year | Lemaitre VascularLMAT, 2025 | Skinhealth SystemsSKIN, 2025 |
|---|---|---|
| Revenue | $250m | $301m |
| Revenue growth | 13.5% | -10.0% |
| Net income | $57.7m | −$9.5m |
| Operating margin | 27.2% | -6.9% |
| Net margin | 23.1% | -3.2% |
| Return on equity | 15.8% | -16.9% |
| Free cash flow | $74.5m | $37.2m |
| Cash | $28.2m | $233m |
| Total debt | $169m | $364m |
| Debt to equity | 42.9% | 596.8% |
| Dividend per share | $0.80 | — |
| Dividend yield | 1.1% | — |
| Share buybacks | $1.8m | $0 |
| Employees | 655 | 613 |
| Market value | $1.85bn | $1.35bn |
| Price vs our value range | Within our value range | Above our value range |
| Moat score | 86 (Strong) | 34 (Weak) |
| Insider trades, 12 months | 0 buys, 11 sales | 0 buys, 0 sales |